| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |